Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-12-506811
Filing Date
2012-12-18
Accepted
2012-12-18 17:29:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 FINAL PROSPECTUS SUPPLEMENT d451855d424b5.htm 424B5 426493
2 GRAPHIC g451855g15q16.jpg GRAPHIC 10274
3 GRAPHIC g451855g64d19.jpg GRAPHIC 60366
  Complete submission text file 0001193125-12-506811.txt   525378
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-167025 | Film No.: 121272340
SIC: 2834 Pharmaceutical Preparations